玻璃体腔注射Avastin治疗新生血管性青光眼的护理
摘要
总结2008年1月~2009年5月对新生血管性青光眼患者12例12眼,采用玻璃体腔内注射Avastin(1.25mg;0.1ml)联合全视网膜激光光凝术的护理。主要包括严格无菌操作,把握手术指征,做好心理护理和常规护理。认为玻璃体腔注射Avastin联合全视网膜激光光凝术治疗新生血管青光眼成功率高,加强围手术期护理,能提高手术效果,避免相关并发症发生。
参考文献7
-
1Lloyd P,Alexander J,Stanley C,et al.Evolving guidelines for intravitreous injections[J].Retina,2004,24(1):S3-S19.
-
2Chilov MN,Grigg JR,Playfair TJ.Bevacizumab(Avastin)for the treatment of neovascular glaucoma[J].CIJn Exp Ophthalmol,2007,35:494-496.
-
3Patel J,Tombran-Tink J,Hykin P,et al.Vitreous and aqneous concentrations of proangiogenic,antiangiogenic factors and other cytokines in diabetic retinopathy patients with macnlar edema:implications for structural differences in macular profiles[J].Exp Eye Res,2006,82(5):798-806.
-
4Ehlers JP,Spirn MJ,Lam A,et al.Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma[J].Retina,2008,28(5):696-702.
-
5Davidorf FH,Mouser JG,Derick RJ.Rapid improvement ofrubeosis iridis from a single bevacizumab(Avastin)injection[J].Retina,2006,26:354-356.
-
6Ehlers JP,Spirn MJ,Lam A,et al.Combination intrayitreal bevacizumab/pantetinal photocoagulation versus pantetinal photocoagulation alone in the treatment of neovascular glaucoma[J].Retina,2008,28(5):696-702.
-
7许薇琦,孙晓东.Bevacizumab眼科应用新进展[J].眼科新进展,2007,27(9):699-703. 被引量:7
二级参考文献40
-
1Ferrara N,Smyth D. The biology of vascular endothelial growth factor[ J]. Endocr Rev 1997 ; 18:4-25.
-
2Miller JW, Chtmg CY, Kim R. Radomized, controlled, phase III study of ranibizumab ( Lucentis ) for minimally classic or occult neovasollar age-related macular degeneration[ C ] .American Society of Retina Specialists Meeting; 2005 : Montreal, Canada.
-
3Mordenti J, Thomsen K, Licko V, Berleau L, Kahn JW, Cuthbertson RA, et al. Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitrcal administration of a solution or a PI/3A microsphere formtdation[ J].Toxicol Sci 1999 ;52( l ) :101-106.
-
4Manzano RP,Peyman GA,Khan P, Kivilcim M. Testing intravitreal toxicity of bevacizumab ( Avastin ) [ J ]. Retina 2006 ;26(3 ) :257-261.
-
5Kiss C, Michels S, Prager F, Weigert G, Geitzenauer W, Schmidt-Erfurth U. Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab[ J]. Retina 2006 ;26( 8 ) :877-881.
-
6Meyer CH, Mennel S, Schmidt JC. Acute retinal pigment epithelial tear following intravitreal bevacizumab(Avastin) injection for occttlt choroidal neovascttlarization secondary to age related macular degeneration [J]. Br d Ophthalmol 2006 ;90(9 ) : 1207-1208.
-
7Singh RP,Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration[ J]. Am J Ophthalmol 2006 ; 142 ( 1 ) : 160-162.
-
8Goldstein M, Heflwefl G, Barak A, Loewenstein A. Retlnal pigment epithelial tear following photodynamic therapy for choroidal neovasoalarization secondary to AMD [ J ]. Eye 2005;19(12) :1315-1324.
-
9Presta LG,Chen H,O' Connor SJ,Chishohn V,Meng YG, Krtmtmen L,et al. Humanization of an anti-vascular endo- thelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders [J]. Cancer Res 1997 ; 57(20) :4593-4599.
-
10Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil,and leucovorin for metastatic colorectal cancer [J]. N Engl J Med 2004 ;350 ( 23 ) :2335-2342.
共引文献6
-
1冯斐,赵培泉.Avastin在眼科的应用研究进展[J].眼科新进展,2009,29(3):231-233. 被引量:9
-
2许薇琦,钱锦,孙晓东,张娴,吴颖,许迅,张皙.抗血管内皮生长因子bevacizumab兔眼玻璃体腔重复注射的安全性研究[J].中华眼底病杂志,2010,26(1):27-31. 被引量:1
-
3买迪娜,李全智,王鸿雁.年龄相关性黄斑变性的中西医治疗进展概况[J].新疆中医药,2010,28(1):71-74.
-
4杨卫民.阿瓦斯汀玻璃体腔内注射治疗黄斑水肿的临床观察[J].眼外伤职业眼病杂志,2010,32(10):762-763. 被引量:1
-
5刘澍,马楠,王首雁,陈国民,孙晓晶,潘婧.玻璃体内注射Bevacizumab联合全视网膜光凝及复合式小梁切除术治疗新生血管性青光眼[J].眼科新进展,2010,30(11):1054-1056. 被引量:6
-
6许昌林,金杰,赵成和.Bevacizumab在糖尿病视网膜病变治疗中的应用[J].中国医药导报,2010,7(35):9-11. 被引量:3
-
1马铮铮.糖尿病性视网膜病变病人行玻璃体切割术联合抗VEGF注射治疗的护理[J].全科护理,2016,14(10):1015-1016. 被引量:4
-
2邱帅.玻璃体腔注射Avastin治疗老年性黄斑变性的手术配合体会[J].按摩与康复医学,2015,6(8):107-108.
-
3邵利云,陈尧.糖尿病视网膜病变手术病人的护理[J].齐鲁医学杂志,2009,24(2):175-175.
-
4高爽,万李丹.视网膜激光光凝术围手术期的护理体会[J].当代护士(下旬刊),2012,19(9):101-102. 被引量:2
-
5刁小菊,刘宝琼,胡小春.Avastin联合多西紫杉醇治疗晚期乳腺癌病人的护理[J].护理研究(上旬版),2011,25(11):2880-2882.
-
6章莹月,姜蕾,刘鲁霞,邹红,叶艳敏,李同亮.新生血管性青光眼玻璃体腔内注射Avastin的护理[J].西南国防医药,2010,20(9):1000-1001. 被引量:1
-
7李彩娟,刘春凤.甲状腺肿瘤彩色多普勒血流显像与微血管密度、血管内皮生长因子表达的研究[J].临床超声医学杂志,2005,7(5):307-309. 被引量:4
-
8朱小丽.玻璃体腔注射抗VEGF药物治疗糖尿病视网膜病变的相关指标观察[J].现代诊断与治疗,2015,26(13):3080-3081. 被引量:6
-
9杜巧芳.玻璃体腔注射抗血管内皮生长因子单克隆抗体Bevacizumab治疗糖尿病性黄斑水肿的护理[J].山东医学高等专科学校学报,2015,37(4):279-280.
-
10陈海侠,李晓薇.1例慢性肾衰竭合并新生血管性青光眼病人的围术期护理[J].全科护理,2009,7(24):2253-2254. 被引量:2